A. Arduini et al., EFFECT OF PROPIONYL-L-CARNITINE TREATMENT ON MEMBRANE PHOSPHOLIPID FATTY-ACID TURNOVER IN DIABETIC RAT ERYTHROCYTES, Molecular and cellular biochemistry, 152(1), 1995, pp. 31-37
In this work we have examined the effect of the oral administration of
propionyl-l-carnitine (PLC) on the membrane phospholipid fatty acid t
urnover of erythrocytes from streptozotocin-induced diabetic rats. A s
tatistically significant reduction in radioactive palmitate, oleate, a
nd linoleate, but not arachidonate, incorporation into membrane phosph
atidylcholine (PC) of diabetic rat erythrocytes with respect to contro
l animals was found. Changes in radioactive fatty acid incorporation w
ere also found in diabetic red cell phosphatidylethanolamine (PE), tho
ugh they were not statistically significant. Oral propionyl-L-carnitin
e (PLC) treatment of diabetic rats partially restored the ability of i
ntact red cells to reacylate membrane PC with palmitate and oleate, an
d reacylation with linoleate was fully restored. The analysis of the m
embrane phospholipid fatty acid composition revealed a consistent incr
ease of linoleate levels in diabetic rat red cells, and a modest decre
ase of palmitate, oleate and arachidonate. The phospholipid fatty acid
composition of diabetic red blood cells was not affected by the PLC t
reatment. Lysophosphatidylcholine acyl-CoA transferase (LAT) specific
activity measured with either palmitoyl-CoA or oleyl-CoA was significa
ntly reduced in diabetic erythrocyte membranes in comparison to contro
ls. In addition, LAT kinetic parameters of diabetic erythrocytes were
altered. The reduced LAT activity could be partially corrected by PLC
treatment of diabetic rats. Our data suggest that the impaired erythro
cyte membrane physiological expression induced by the diabetic disease
may be attenuated by the beneficial activity of PLC on the red cell m
embrane phospholipid fatty acid turnover.